Veradermics Inc., a biopharmaceutical firm focused on hair restoration, raised $256.3 million in an upsized US initial public ...

Exxel Pharma is eyeing a listing on the NYSE American to fund human trials for a drug class that has previously struggled to ...

Hong Kong’s market regulator stepped up warnings to investment banks over filing sloppy applications for share sales as ...

Once Upon a Farm had annual sales of $226 million as of Sept. 30, 2025, and incurred a loss of $52 million during the period, ...

By Arasu Kannagi Basil and Pritam Biswas Jan 20 (Reuters) - Clear Street recorded a 160% revenue jump in the first nine ...

Jan 28 (Reuters) - U.S. software maker Anaplan could file confidentially for an initial public offering in the coming weeks, ...

Jan 16 (Reuters) - Biopharmaceutical company Agomab Therapeutics filed for an initial public offering in the United States on Friday. IPOs are likely to gain momentum in 2026 as anticipated interest ...

Zoom Communications owns up to $4B in Anthropic equity, offering a potential IPO-driven upside catalyst. Learn why ZM stock ...

Medikra has filed for an initial public offering. The biopharmaceutical company said it will sell about 3.6 million units at $5 to $6 apiece, according to a filing with the Securities and Exchange ...

Bain Capital-backed Dhoot Transmission, a manufacturer in the auto components sector, has confidentially filed its DRHP with ...

Shares will have a face value of ₹2 each and are planned for listing on both BSE and NSE, the company said.

Anaplan, a business-planning software provider owned by private equity firm Thoma Bravo, is taking steps toward an initial ...